Interestingly, the up-regulation of proteins involved in the above-mentioned pathways (i.e., Ndufab1, Sdhb, Uqcrc2) in our PS19 mice exposed to fasudil treatment highlight its promising potential by targeting these molecular signatures of AD pathogenesis. This evidence concerns the gene SDHB and Alzheimer disease.